FDA Inspection 1167863 — Athena GTX Inc.

Athena GTX Inc. — FEI 3007413079

The FDA completed an inspection of Athena GTX Inc. on Apr 21, 2022 in Johnston, IA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 21, 2022
Fiscal Year
2022
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Johnston, IA (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
311921 CFR 820.75(b)Lack/Inad procedure-Monitoring/Control of Validated Proces